RYBELTIS Trademark

Trademark Overview

On Friday, September 29, 2017, a trademark application was filed for RYBELTIS with the United States Patent and Trademark Office. The USPTO has given the RYBELTIS trademark a serial number of 87627563. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 8, 2020. This trademark is owned by Novo Nordisk A/S. The RYBELTIS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of diabetes
rybeltis

General Information

Serial Number87627563
Word MarkRYBELTIS
Filing DateFriday, September 29, 2017
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 8, 2020
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, February 6, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, October 4, 2017
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovo Nordisk A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBagsvaerd 2880
DK
Party NameNovo Nordisk A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBagsvaerd 2880
DK

Trademark Events

Event DateEvent Description
Monday, June 8, 2020ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 8, 2020ABANDONMENT - NO USE STATEMENT FILED
Saturday, October 5, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 3, 2019EXTENSION 3 GRANTED
Thursday, October 3, 2019EXTENSION 3 FILED
Thursday, October 3, 2019TEAS EXTENSION RECEIVED
Thursday, October 3, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 3, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, February 21, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 19, 2019EXTENSION 2 GRANTED
Tuesday, February 19, 2019EXTENSION 2 FILED
Tuesday, February 19, 2019TEAS EXTENSION RECEIVED
Friday, September 28, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 26, 2018EXTENSION 1 GRANTED
Wednesday, September 26, 2018EXTENSION 1 FILED
Wednesday, September 26, 2018TEAS EXTENSION RECEIVED
Tuesday, April 3, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, February 6, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 6, 2018PUBLISHED FOR OPPOSITION
Wednesday, January 17, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, December 29, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, December 29, 2017ASSIGNED TO EXAMINER
Wednesday, October 4, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, October 3, 2017NEW APPLICATION ENTERED IN TRAM

Related Keywords

rybeltis diabetes treatment preparations pharmaceutical